Europe: Medical Devices - The Notified Body Consultation Procedure, Part 2
27/9/2011
Manufacturers of medical devices incorporating ancillary substances should have a clear understanding of the consultation procedure that their Notified Body will have to follow.
Part 1 discussed the regulatory requirements and important guidance documents.
Part 2 covers aspects of the process itself, required documentation and fees. More...
Author: Greer Deal, Director of Global Regulatory Services (GRS)